Walleye Capital LLC Dexcom Inc Put Options Transaction History

Walleye Capital LLC

12 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$64.0 - $116.06 $1.14 Million - $2.07 Million	17,800 Added 5.58%	337,000 $22.6 Million
Q2 2024 Aug 14, 2024	SELL	$110.31 - $140.45 $2.8 Million - $3.57 Million	-25,400 Reduced 7.37%	319,200 $36.2 Million
Q1 2024 May 15, 2024	SELL	$114.22 - $140.1 $37.6 Million - $46.1 Million	-329,300 Reduced 48.86%	344,600 $47.8 Million
Q4 2023 Feb 14, 2024	BUY	$75.49 - $124.16 $3.09 Million - $5.08 Million	40,900 Added 6.46%	673,900 $83.6 Million
Q3 2023 Nov 14, 2023	SELL	$86.06 - $137.93 $318,422 - $510,341	-3,700 Reduced 0.58%	633,000 $59.1 Million
Q2 2023 Aug 14, 2023	BUY	$112.47 - $130.98 $71.1 Million - $82.8 Million	632,100 Added 13741.3%	636,700 $81.8 Million
Q1 2023 May 15, 2023	BUY	$104.0 - $122.92 $478,400 - $565,432	4,600 New	4,600 $534,000
Q3 2022 Nov 14, 2022	BUY	$76.35 - $94.18 $22,905 - $28,254	300 New	300 $24,000
Q4 2019 Feb 14, 2020	BUY	$36.62 - $57.29 $10,986 - $17,187	300 New	300 $66,000
Q3 2019 Nov 14, 2019	SELL	$35.53 - $43.8 $35,530 - $43,800	-1,000 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$27.84 - $38.92 $64,032 - $89,516	-2,300 Reduced 69.7%	1,000 $150,000
Q1 2019 May 15, 2019	BUY	$28.07 - $38.18 $92,631 - $125,994	3,300 New	3,300 $393,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.